Search Results
Sep 03, 2026, 09:00 ET NUHS AND ITS INSTITUTIONS SECURE GOLD AND MULTIPLE AWARDS AT HOSPITAL MANAGEMENT ASIA AWARDS 2026
pipeline of future leaders. The initiative has now been recognised with Gold in the "Best in Talent Development" category at the Hospital Management Asia (HMA) Awards 2026.
More news about: National University Health System (NUHS)
Aug 19, 2026, 08:00 ET Healthcare Management Administrators partners with Carrot to deliver fertility and family care benefits to employer groups across the Pacific Northwest and Michigan
reflects HMA's Winning Together philosophy — better health for members, better value for plan sponsors," said Diane Zalewski, president and CEO of HMA."HMA has been a trusted partner to self-funded employers for over 40 years. These are the exact plan sponsors that Carrot was built for – those who
More news about: Carrot Fertility, Inc.
Aug 10, 2026, 12:00 ET Healthcare Management Administrators Appoints Diane Zalewski as CEO
healthcare executive whose experience, vision and leadership style make her uniquely qualified to lead HMA into its next chapter," said Lindsay Harris, chief commercial officer at Cambia Health Solutions and HMA Board Member. "Throughout the search process, Diane consistently demonstrated a deep understanding
More news about: Healthcare Management Administrators, Inc.
Jul 15, 2026, 08:23 ET Jay Reavis Named Holmes Murphy President
July 15, 2026 /PRNewswire/ -- Holmes Murphy announced today that Jay Reavis has been named President of Holmes Murphy and HMA Group Holdings. This appointment reflects the company's ongoing commitment to the power of its independence, leadership development, thoughtful succession
More news about: Holmes Murphy
Jul 08, 2026, 15:00 ET Health Management Associates Names Arda Ural Chief Operating Officer
and managed the U.S. Celebrex franchise.Ural will be based in HMA's New York City office.About Health Management Associates (HMA)HMA is an independent, national research and consulting firm specializing in publicly funded healthcare and human services policy, programs, financing,
More news about: Health Management Associates
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
post-remission administration of G-CSF and treatment initiation setting on safety and effectiveness outcomes with venetoclax plus hypomethylating agents (HMA) in newly diagnosed AML patients unfit for intensive chemotherapy.5Etentamig in patients with relapsed/refractory
More news about: AbbVie
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
post-remission administration of G-CSF and treatment initiation setting on safety and effectiveness outcomes with venetoclax plus hypomethylating agents (HMA) in newly diagnosed AML patients unfit for intensive chemotherapy.5Etentamig in patients with relapsed/refractory
More news about: AbbVie
May 27, 2026, 12:33 ET During Mental Health Awareness Month, New Report Highlights the High Cost of Treatment‑Resistant Depression and Gaps in Access to Care
here.About Health Management Associates (HMA)HMA is an independent, national research and consulting
More news about: Health Management Associates
May 12, 2026, 11:45 ET Asphalt Paving Material Market to Reach USD 395 Billion by 2033, Driven by Expanding Infrastructure Development and Demand for Durable Road Construction Materials: Verified Market Research
cost efficiency, flexibility, and load-bearing capabilities.The market includes several asphalt material categories such as hot mix asphalt (HMA), warm mix asphalt (WMA), cold mix asphalt, polymer-modified asphalt, and other specialized paving products. These materials are integrated with advanced
More news about: Verified Market Research
May 12, 2026, 09:00 ET New National Collaborative Aims to Improve Our National Response to People in Mental Health Crisis
National Alliance on Mental Illness (NAMI) and Health Management Associates (HMA) Launch the National Collaborative for Crisis Systems InnovationARLINGTON, Va., May 12, 2026 /PRNewswire/ -- Today,
More news about: National Alliance on Mental Illness (NAMI)
May 05, 2026, 09:00 ET TempoPay and HMA Announce Partnership to Expand Flexible Healthcare Payment Options for Members
partnership between HMA and TempoPay provides a powerful solution.TempoPay delivers a cost‑effective solution for employers while giving employees access to interest‑free funds and simplified payments, removing financial friction so they can say yes to care with confidence."At HMA, we are constantly
More news about: TempoPay
Apr 26, 2026, 21:50 ET 亞盛醫藥Bcl-2抑制劑利生妥®獲 2026 版 CSCO系列指南多項重磅推薦
抑制劑（包含利沙托克拉）」聯合去甲基化藥物（AZA/DAC）或低劑量阿糖胞甘（LDAC）列為一線方案的核心推薦 。耐藥患者突破： 特別是針對既往有 HMA 暴露的 Unfit 患者，指南新增了「LDAC+ Bcl-2抑制劑」方案。利沙托克拉憑借其獨特的藥代動力學優勢，成為此類經治/耐藥患者的重要替代選擇 。難治/復發挽救：對早期復發患者靶向治療或靶向聯合化療時，指南新增了利沙托克拉同樣可作為Bcl-2抑制劑的可選藥物。三、 MDS 領域：延續了 Bcl-2抑制劑 聯合 HMA 在較高危MDS中的治療價值在2026版《CSCO 惡性血液病診療指南》中，對
More news about: 亞盛醫藥
Apr 15, 2026, 13:21 ET Wakely Analysis Signals Significant Enrollment Shifts in ACA Individual Market as 2026 Unfolds
Consulting Group, an HMA CompanyFounded in 1999, Wakely Consulting Group, an HMA Company,
More news about: Wakely Consulting Group
Apr 07, 2026, 08:10 ET Forty Years Strong: HMA Marks Four Decades Serving Self-Funded Employers
serves."This anniversary is really about the people behind the progress," said Kimberley Bryant, Chief Operating Officer at HMA. "Our clients, broker partners, and HMA team have grown with us, challenged us, and trusted us over the years. While our industry has continued to evolve, our purpose has
More news about: Healthcare Management Administrators, Inc.
Mar 27, 2026, 15:09 ET HMA Acquires HealthTech Solutions, Expanding Technology Capabilities and Medicaid Expertise
continue to operate as HealthTech Solutions, an HMA Company. Terms of the transaction were not disclosed. Synergy Advisors served as exclusive financial advisor to HealthTech Solutions in this transaction.About Health Management Associates (HMA)HMA is an independent, national research and consulting
More news about: Health Management Associates
Mar 17, 2026, 11:29 ET Hot Melt Adhesives Market Size to Surpass USD 14.5 Billion by 2032, Shows New Maximize Market Research Analysis
Industry DevelopmentsOn 11 February 2026, Jowat SE acquired KOMO Certification for building element adhesives, validating HMA reliability for the global window, door, and façade industry. On 4 February 2026, H.B. Fuller hosted a Global CEO Huddle in Chongqing,
More news about: Maximize Market Research Pvt. Ltd.
Mar 12, 2026, 18:19 ET THRIVING NATIONAL HEALTHCARE COMMUNICATIONS FIRM EXPANDS TEAM
expert in corporate and internal communications, digital engagement, crisis management and brand position, Longman previous held leadership positions at HMA and Merck.
More news about: Jarrard Inc.
Feb 17, 2026, 07:42 ET Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
Actimab-A, Venetoclax (Abbvie/Roche) an oral Bcl-2 inhibitor and ASTX-727 (Taiho Oncology, an Otsuka holdings company) a novel oral hypomethylating agent (HMA) in frontline acute myeloid leukemia (AML) patients. Additionally, Actinium is developing Actimab-A as a potential pan tumor therapy in combination with
More news about: Actinium Pharmaceuticals, Inc.
Jan 09, 2026, 12:00 ET Lucent Health Names Aadam Hussain as Chief Executive Officer Following Brett Rodewald's Retirement
Officer of Healthcare Management Administrators (HMA), where he led a national third-party administrator overseeing strategy, plan administration, client services, member engagement, regulatory compliance, and operational execution.Prior to HMA, Aadam held senior executive leadership roles at
More news about: Lucent Health
Dec 16, 2025, 11:36 ET HASC Releases Regional Behavioral Health Scan Showing Rising Needs and Continued Progress Across Southern California
Association of Southern California (HASC) has released a new Comprehensive Behavioral Health Environmental Scan conducted with Health Management Associates (HMA). The report provides an updated look at behavioral health needs, system pressures and areas of progress across Los Angeles, Orange, Riverside, San Bernardino,
More news about: Hospital Association of Southern California
Dec 12, 2025, 08:45 ET Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025
Actimab-A, Venetoclax (Abbvie/Roche) an oral Bcl-2 inhibitor and ASTX-727 (Taiho Oncology, an Otsuka holdings company) a novel oral hypomethylating agent (HMA) in frontline acute myeloid leukemia (AML) patients. Additionally, Actinium is developing Actimab-A as a potential pan tumor therapy in combination with
More news about: Actinium Pharmaceuticals, Inc.
Dec 07, 2025, 09:30 ET Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
patients had received luspatercept, 73% (24) had received an erythropoiesis stimulating agent (ESA), 67% (22) had received an hypomethylating agent (HMA) and 6% (2) had received imetelstat. 61% (20) of patients were high transfusion burden (HTB) at baseline. 67% (22) of patients were ring sideroblast
More news about: Rigel Pharmaceuticals, Inc.
Dec 01, 2025, 08:45 ET Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
Actimab-A, Venetoclax (Abbvie/Roche) an oral Bcl-2 inhibitor and ASTX-727 (Taiho Oncology, an Otsuka holdings company) a novel oral hypomethylating agent (HMA) in frontline acute myeloid leukemia (AML) patients. Additionally, Actinium is developing Actimab-A as a potential pan tumor therapy in combination with
More news about: Actinium Pharmaceuticals, Inc.
Dec 01, 2025, 08:00 ET Blood Cancer United Showcases Bold Research and Vision at 2025 ASH Annual Meeting
RAS mutations negate the favorable impact of NPM1 in older patients with newly diagnosed Acute Myeloid Leukemia treated with ven/HMADecember 85:30 to 5:45 p.m. ET
More news about: Blood Cancer United® formerly The Leukemia & Lymphoma Society
Nov 19, 2025, 09:07 ET Lightbeam Health Solutions and Wakely Consulting Group Partner to Launch Predictive ACO Optimization Tools for Value-Based Care Leaders
Wakely Consulting Group, an HMA company, to launch two powerful tools – ACO Optimization Retrosight (AOR) and ACO Optimization Futuresight (AOF). Together, these solutions empower Accountable
More news about: Lightbeam Health Solutions